Innovative drugs for cancer patients

Our values, experience and commitment are the keys to developing better drugs for patients with cancer.

Learn more about our clinical trials

A pioneering spirit is our driving force

We are curious by nature and seek to address fundamental questions in cancer biology which we hope will result in better drugs for patients with cancer.

Learn more about our products

One team – one goal

We are united by our shared values, and a sense of fairness and curiosity.

Learn more about 4SC

Success secures our future

Experience and expertise lead to better decision making, informative data and peer and patient recognition – the foundation for our success.

Learn more about our perspectives

Transparency for partners

Continuous exchange and open communication create value and long-standing partnerships.

Learn more about our partners

Events

1112/17

London Non Deal Roadshow

11.12.17London, United Kingdom
1212/17

Frankfurt Non Deal Roadshow

12.12.17Frankfurt am Main, Germany
1312/17

Munich Non Deal Roadshow

13.12.17Munich, Germany

All events

4SC AG: Developing innovative drugs for cancer patients

Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biopharmaceutical company with a strong focus on product development in oncology.

We develop novel small molecule drugs for the treatment of cancer in indications with a high unmet medical need and significant economic potential.

We wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life.

Our product pipeline comprises promising drug programs at various stages of clinical development. We are focusing on fields of research that contribute to the development and persistence of cancer.

Learn more about 4SC

Share this page:

Follow us on: